TABLE 1

Features of patients who may benefit from long-term teriparatide use

Very high fracture risk, unable to come off glucocorticoid therapy
High fracture risk, with P1NP level that remains high after 2 years on teriparatide
High fracture risk, with multiple vertebral compression fractures at baseline but none while on teriparatide
Adynamic renal bone disease
Severe chronic obstructive pulmonary disease and vertebral compression fractures

  • P1NP = procollagen type 1 N-terminal propeptide